The stock of Novo Integrated Sciences Inc. (NASDAQ:NVOS) decreased by -$0.01 on Monday to finish at $0.07, down -9.91 percent. The last five days have seen an average of 3,997,800 shares of common stock traded. 2 times new highs were reached in the current year, with a fall of -$0.1302. The average number of shares traded over the last 20 days was 3,850,375, while the average volume over the last 50 days totaled 4,408,958.
NVOS stock dropped -44.82% since last month. On 08/14/23, the company’s shares reached a one-month low of $0.0690. The stock touched a high of $1.89 on 01/09/23, after rallying from a low of $0.08 in 52 weeks. The price of NVOS stock has declined by -64.74% or -$0.1302 this year, reaching a new high 2 times. Still, the stock price is down -96.25% from the 52-week high.
Valuation Metrics
Beta for the stock is -0.13. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 9.26, the price-to-book (PB) ratio of 0.37.
Financial Health
For the recent quarter, Novo Integrated Sciences Inc.’s quick ratio was 0.50, while its current ratio was 0.60, indicating its inability to pay off its debt. Based on annual data, it had gross profit of $4.8 million and revenue of $11.74 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. There was a -75.80% return on investment (ROI) in the past year.
Earnings Surprise
A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $3.29 million, while revenues rose by 12.77% to $3.42 million. EBITDA was -$0.69 million for the quarter. At the end of Novo Integrated Sciences Inc.’s most recent quarter, its liabilities totaled 9.45 million, while its total debt was $4.58 million. Equity owned by shareholders amounts to $148.43 million.
Technical Picture
Here’s a quick look at Novo Integrated Sciences Inc.’s (NVOS) price momentum from a technical perspective. As of 14 August, the RSI 9-day stood at 13.36%, suggesting the stock is oversold, with a 64.96% historical volatility rate.
The stochastic %K and %D were 5.57% and 9.43% respectively, while the average true range (ATR) was 0.0091. Based on the 14-day stochastic reading of 3.52%, the RSI (14) reading is 20.53%. On the 9-day MACD Oscillator, the stock is at -0.0133, and the 14-day reading is at -0.0208.
Analyst Ratings
Analysts have assigned Novo Integrated Sciences Inc. (NVOS) an – rating. NVOS is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
